Transforming innovative bio-convergence and life science research into successful industrial value to lead the global ecosystem
Y-TCC serves as a core hub dedicated to ensuring that outstanding foundational research and cutting-edge technologies do not remain confined to the laboratory, but actively contribute to the industry and improve patients' lives.
We bridge the gap between academic researchers and industry leaders. By providing tailored strategies across the entire tech lifecycle—from early-stage discovery to commercialization—we build highly successful academia-industry collaboration models.
Core Services
- IP Strategy & Portfolio EnhancementDiscovering promising research outcomes and supporting the design of robust, globally competitive patent portfolios.
- Tech Transfer & LicensingConducting industry demand analysis for target profiling, matching technologies with optimal corporate partners, and facilitating license negotiations.
- Startup & Spin-off SupportIncubating lab-based venture startups, planning early-stage drug development pipelines, and advising on sustainable business model (BM) establishment.
- Strategic Consulting & PartnershipsReviewing the commercial viability of biotech and pharmaceutical technologies, and facilitating academic-industry networks for joint research initiatives.
Key Technology Areas
• Drug Discovery & Pipelines : Targeted therapeutics, innovative new drug candidates, and advanced modalities.
• Bio-Healthcare & Convergence : Advanced diagnostic technologies, precision medicine, and digital health solutions.
Contact Information
Head of Y-DDC,
swoh33@yonsei.ac.kr
Research Coordinator
woh@yonsei.ac.kr